Prenatal Diagnosis and Screening of Thalassemia Mutations in Bangladesh: Presence of Rare Mutations

References

• Kountouris P, Lederer CW, Fanis P, et al. IthaGenes: an interactive database for haemoglobin variations and epidemiology. PLoS One. 2014;9(7):e103020.
   PubMed Web of Science ®Google Scholar
• Ladis V, Karagiorga-Lagana M, Tsatra I, et al. Thirty-year experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimisation. Eur J Haematol. 2013;90(4):313–322.
   PubMed Web of Science ®Google Scholar
• Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. The inherited disorders of haemoglobin are an emerging global health burden. Bull World Health Organ. 2010;115(22):4331–4336.
   Google Scholar
• Tahura S, Selimuzzaman M, Khan WA. Thalassaemia prevention: Bangladesh perspective – a current update. Bangladesh J Child Health. 2016;40(1):31–38.
   Google Scholar
• Aziz A, Ahmed W, Sarwardi G. Molecular analysis of Hb E and β-thalassemia major patients among Bangladeshi population. Austin J Biotechnol Bioeng. 2017;4(4):1085.
   Google Scholar
• Noor FA, Sultana N, Bhuyan GS, et al. Nationwide carrier detection and molecular characterization of β-thalassemia and Hemoglobin E variants in Bangladeshi population. Orphanet J Rare Dis. 2020;15(1):15–27.
   PubMed Web of Science ®Google Scholar
• Varawalla NY, Old JM, Sarkar R, et al. The spectrum of beta-thalassaemia mutations on the Indian subcontinent: the basis for prenatal diagnosis. Br J Haematol. 1991;78(2):242–247.
   PubMed Web of Science ®Google Scholar
• Sultana GNN, Begum R, Akhter H, et al. The complete spectrum of beta (β) thalassemia mutations in Bangladeshi population. Austin Biomark Diagn. 2016;3(1):1024–1030.
   Google Scholar
• Ibn Ayub M, Moosa MM, Sarwardi G, et al. Mutation analysis of the HBB gene in selected Bangladeshi beta-thalassemic individuals: presence of rare mutations. Genet Test Mol Biomarkers. 2010;14(3):299–302.
   PubMed Web of Science ®Google Scholar
• Banu B, Khan WA, Selimuzzaman M, et al. Mutation pattern in β thalassaemia trait population: a basis for prenatal diagnosis. Bangladesh Med Res Counc Bull. 2018;44(2):65–70.
   Google Scholar
• Ahmed S. Prenatal diagnosis of beta-thalassemia: 12 years' experience at a single laboratory in Pakistan. Prenat Diagn. 2007;27(13):1224–1227.
   PubMed Web of Science ®Google Scholar
• Cao A, Galanello R. Effect of consanguinity on screening for thalassemia. N Engl J Med. 2002;347(15):1200–1202.
   PubMed Web of Science ®Google Scholar
• Angastiniotis MA, Hadjiminas MG. Prevention of thalassemia in Cyprus. Lancet. 1991;1(8216):369–370.
   Google Scholar
• Petrou M, Modell B. Prenatal screening for haemoglobin disorders. Prenat Diagn. 1995;15(13):1275–1295.
   PubMed Web of Science ®Google Scholar
• Loukopoulos D. Current status of thalassaemia and the sickle cell disorders in Greece. Semin Hematol. 1996;33(1):76–86.
   PubMed Web of Science ®Google Scholar
• Alfirevic Z, Navaratnam K, Mujezinovic F. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2017;9(9):CD003252.
   PubMedGoogle Scholar
• Günel T, Hosseini MK, Gümüşoğlu E, et al. Current approaches on non-invasive prenatal diagnosis: prenatal genomics, transcriptomics, personalized fetal diagnosis. Turk J Obstet Gynecol. 2014;11(4):233–241.
   PubMedGoogle Scholar
• Wieacker P, Steinhard J. The prenatal diagnosis of genetic diseases. Dtsch Arztebl Int. 2010;107(48):857–862.
   PubMed Web of Science ®Google Scholar
• Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27(1):1–7.
   PubMed Web of Science ®Google Scholar
• Rodeck C, Tutschek B, Sherlock J, et al. Methods for the transcervical collection of fetal cells during the first trimester of pregnancy. Prenat Diagn. 1995;15(10):933–942.
   PubMed Web of Science ®Google Scholar
• Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol. 2006;108(3, Pt 1):612–616.
   PubMed Web of Science ®Google Scholar
• Giardine B, van Baal S, Kaimaki P, et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat. 2007;28(2):206.
   PubMed Web of Science ®Google Scholar
• Ferdous F, Eunus Ali M, Alam S, et al. Genetic data on 10 autosomal STR loci in the Bangladeshi population. Leg Med. 2006;8(5):297–299.
   PubMedGoogle Scholar
• White HW, Kusukawa N. Agarose-based system for separation of short tandem repeat loci. Biotechniques. 1997;22(5):976–980.
   PubMed Web of Science ®Google Scholar
• Old J, Harteveld CL, Traeger-Synodinos J, et al. editors. Molecular diagnosis. Prevention of thalassaemias and other haemoglobin disorders. 2nd ed. Nicosia (Cyprus): Thalassaemia International Federation; 2012. p. 74–78. www.ncbi.nlm.nih.gov/books/NBK190571/.
   Google Scholar
• Chatterjee T, Chakravarty A, Chakravarty S, et al. Mutation spectrum of β-thalassemia and other hemoglobinopathies in Chittagong, Southeast Bangladesh. Hemoglobin. 2015;39(6):389–392.
   PubMed Web of Science ®Google Scholar
• Najmabadi H, Ghamari A, Sahebjam F, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet. 2006;9(2):93–97.
   PubMedGoogle Scholar
• Verma IC, Saxena R, Kohli S. Past, present & future scenario of thalassaemic care & control in India. Indian J Med Res. 2011;134(4):507–521.
   PubMedGoogle Scholar
• Sadiya S, Nazneen A, Khan WA, et al. Prenatal diagnosis of thalassaemia in a tertiary level hospital by amplification refractory mutation system (ARMS) method. Bangladesh J Child Health. 2017;33(2):119–123.
   Google Scholar
• Aziz A, Das SA, Khan WA, et al. A novel β-thalassemia insertion/frameshift mutation between codons 77/78 (p.Leu78 Profs*13; c.235_236insC) observed in a family in Bangladesh. Hemoglobin. 2017;41(4-6):311–313.
   PubMed Web of Science ®Google Scholar
• Cheng TC, Orkin SH, Antonarakis SE, et al. Beta-thalassemia in Chinese: use of in vivo RNA analysis and oligonucleotide hybridization in systematic characterization of molecular defects. Proc Natl Acad Sci Usa. 1984;81(9):2821–2825.
   PubMed Web of Science ®Google Scholar
• Hattori Y, Yamamoto K, Yamashiro Y, et al. Three β-thalassemia mutations in the Japanese: IVS-II-1 (G→A), IVS-II-848 (C→G), and codon 90 (GAG→TAG). Hemoglobin. 1992;16(1–2):93–97.
   PubMed Web of Science ®Google Scholar
• Rund D, Cohen T, Filon D, et al. Evolution of a genetic disease in an ethnic isolate: beta-thalassemia in the Jews of Kurdistan. Proc Natl Acad Sci USA. 1991;88(1):310–314.
   PubMed Web of Science ®Google Scholar
• Meloni A, Rosatelli MC, Faà V, et al. Promoter mutations producing mild beta-thalassaemia in the Italian population. Br J Haematol. 1992;80(2):222–226.
   PubMed Web of Science ®Google Scholar
• Chan V, Chan TK, Kan YW, et al. A novel beta-thalassemia frameshift mutation (codon 14/15), detectable by direct visualization of abnormal restriction fragment in amplified genomic DNA. Blood. 1988;72(4):1420–1423.
   PubMed Web of Science ®Google Scholar